Akoya to Report Third Quarter 2023 Financial Results on November 8th, 2023
11 Octubre 2023 - 3:05PM
Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial
Biology Company®, today announced that it will release financial
results for the third quarter of 2023 after the market close on
November 8th, 2023. Company management will host a conference call
to discuss financial results at 5:00 p.m. ET.
Investors interested in listening to the conference
call are required to register online. It is recommended to register
at least a day in advance. A live and archived webcast of the event
will be available on the “Investors” section of the Akoya website
at https://investors.akoyabio.com/.
About Akoya Biosciences
As The Spatial Biology Company®, Akoya Biosciences’
mission is to bring context to the world of biology and human
health through the power of spatial phenotyping. The company offers
comprehensive single-cell imaging solutions that allow researchers
to phenotype cells with spatial context and visualize how they
organize and interact to influence disease progression and response
to therapy. Akoya offers a full continuum of spatial phenotyping
solutions to serve the diverse needs of researchers across
discovery, translational and clinical research via its key
platforms: PhenoCycler™, PhenoImager™ Fusion and PhenoImager HT. To
learn more about Akoya, visit www.akoyabio.com.
Investor Contact:Priyam ShahSr.
Director, Investor RelationsAkoya Biosciences,
Inc.investors@akoyabio.com
Media Contact:Christine Quern(617)
650-8497media@akoyabio.com
Akoya BioSciences (NASDAQ:AKYA)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Akoya BioSciences (NASDAQ:AKYA)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024